Circulating endothelial progenitor cells and residual in vivo thromboxane biosynthesis in low-dose aspirin-treated polycythemia vera patients

Francesca Santilli, Mario Romano, Antonio Recchiuti, Alfredo Dragani, Angela Falco, Gianfranco Lessiani, Francesca Fioritoni, Stefano Lattanzio, Domenico Mattoscio, Raimondo De Cristofaro, Bianca Rocca, Giovanni Davì

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

Polycythemia vera (PV) is associated with high morbidity and mortality for thrombosis. We hypothesized that in PV altered sensitivity to aspirin might be related to dysfunction of the endothelial repair and/or of the nitric oxide (NO) system. Urinary thromboxane (TX) A 2 metabolite (TXM). endothelial colony-forming cells (ECFCs), plasma asymmetric dimethyl- arginine (ADMA) and von Willebrand factor (VWF) were measured in 37 PV patients on low-dose aspirin and 12 healthy controls. Patients showed an approximately 2-fold increase in median TXM and plasma ADMA levels (P2 = 0.39). Serum TXB 2, measured in 22 patients, was approximatly 10-fold higher than aspirin-treated controls. PV patients appear to have an unbalanced ECFC/NO axis, and an apparent altered sensitivity of platelet TXA 2 production, all potentially contributing to aspirin- insensitive TXM formation. Thus, additional antithrombotic strategies may be beneficial in PV.

Original languageEnglish
Pages (from-to)1085-1090
Number of pages6
JournalBlood
Volume112
Issue number4
DOIs
Publication statusPublished - Aug 15 2008

Fingerprint

Polycythemia Vera
Thromboxanes
Biosynthesis
Endothelial cells
Aspirin
Metabolites
varespladib methyl
Arginine
Nitric Oxide
Plasmas
von Willebrand Factor
Platelets
Plasma Cells
Repair
Thrombosis
Blood Platelets
Endothelial Progenitor Cells
Morbidity
Mortality
Serum

ASJC Scopus subject areas

  • Hematology
  • Biochemistry
  • Cell Biology
  • Immunology

Cite this

Circulating endothelial progenitor cells and residual in vivo thromboxane biosynthesis in low-dose aspirin-treated polycythemia vera patients. / Santilli, Francesca; Romano, Mario; Recchiuti, Antonio; Dragani, Alfredo; Falco, Angela; Lessiani, Gianfranco; Fioritoni, Francesca; Lattanzio, Stefano; Mattoscio, Domenico; De Cristofaro, Raimondo; Rocca, Bianca; Davì, Giovanni.

In: Blood, Vol. 112, No. 4, 15.08.2008, p. 1085-1090.

Research output: Contribution to journalArticle

Santilli, F, Romano, M, Recchiuti, A, Dragani, A, Falco, A, Lessiani, G, Fioritoni, F, Lattanzio, S, Mattoscio, D, De Cristofaro, R, Rocca, B & Davì, G 2008, 'Circulating endothelial progenitor cells and residual in vivo thromboxane biosynthesis in low-dose aspirin-treated polycythemia vera patients', Blood, vol. 112, no. 4, pp. 1085-1090. https://doi.org/10.1182/blood-2007-11-123091
Santilli, Francesca ; Romano, Mario ; Recchiuti, Antonio ; Dragani, Alfredo ; Falco, Angela ; Lessiani, Gianfranco ; Fioritoni, Francesca ; Lattanzio, Stefano ; Mattoscio, Domenico ; De Cristofaro, Raimondo ; Rocca, Bianca ; Davì, Giovanni. / Circulating endothelial progenitor cells and residual in vivo thromboxane biosynthesis in low-dose aspirin-treated polycythemia vera patients. In: Blood. 2008 ; Vol. 112, No. 4. pp. 1085-1090.
@article{82679dbae692446b9604d3250cacdca4,
title = "Circulating endothelial progenitor cells and residual in vivo thromboxane biosynthesis in low-dose aspirin-treated polycythemia vera patients",
abstract = "Polycythemia vera (PV) is associated with high morbidity and mortality for thrombosis. We hypothesized that in PV altered sensitivity to aspirin might be related to dysfunction of the endothelial repair and/or of the nitric oxide (NO) system. Urinary thromboxane (TX) A 2 metabolite (TXM). endothelial colony-forming cells (ECFCs), plasma asymmetric dimethyl- arginine (ADMA) and von Willebrand factor (VWF) were measured in 37 PV patients on low-dose aspirin and 12 healthy controls. Patients showed an approximately 2-fold increase in median TXM and plasma ADMA levels (P2 = 0.39). Serum TXB 2, measured in 22 patients, was approximatly 10-fold higher than aspirin-treated controls. PV patients appear to have an unbalanced ECFC/NO axis, and an apparent altered sensitivity of platelet TXA 2 production, all potentially contributing to aspirin- insensitive TXM formation. Thus, additional antithrombotic strategies may be beneficial in PV.",
author = "Francesca Santilli and Mario Romano and Antonio Recchiuti and Alfredo Dragani and Angela Falco and Gianfranco Lessiani and Francesca Fioritoni and Stefano Lattanzio and Domenico Mattoscio and {De Cristofaro}, Raimondo and Bianca Rocca and Giovanni Dav{\`i}",
year = "2008",
month = "8",
day = "15",
doi = "10.1182/blood-2007-11-123091",
language = "English",
volume = "112",
pages = "1085--1090",
journal = "Blood",
issn = "0006-4971",
publisher = "American Society of Hematology",
number = "4",

}

TY - JOUR

T1 - Circulating endothelial progenitor cells and residual in vivo thromboxane biosynthesis in low-dose aspirin-treated polycythemia vera patients

AU - Santilli, Francesca

AU - Romano, Mario

AU - Recchiuti, Antonio

AU - Dragani, Alfredo

AU - Falco, Angela

AU - Lessiani, Gianfranco

AU - Fioritoni, Francesca

AU - Lattanzio, Stefano

AU - Mattoscio, Domenico

AU - De Cristofaro, Raimondo

AU - Rocca, Bianca

AU - Davì, Giovanni

PY - 2008/8/15

Y1 - 2008/8/15

N2 - Polycythemia vera (PV) is associated with high morbidity and mortality for thrombosis. We hypothesized that in PV altered sensitivity to aspirin might be related to dysfunction of the endothelial repair and/or of the nitric oxide (NO) system. Urinary thromboxane (TX) A 2 metabolite (TXM). endothelial colony-forming cells (ECFCs), plasma asymmetric dimethyl- arginine (ADMA) and von Willebrand factor (VWF) were measured in 37 PV patients on low-dose aspirin and 12 healthy controls. Patients showed an approximately 2-fold increase in median TXM and plasma ADMA levels (P2 = 0.39). Serum TXB 2, measured in 22 patients, was approximatly 10-fold higher than aspirin-treated controls. PV patients appear to have an unbalanced ECFC/NO axis, and an apparent altered sensitivity of platelet TXA 2 production, all potentially contributing to aspirin- insensitive TXM formation. Thus, additional antithrombotic strategies may be beneficial in PV.

AB - Polycythemia vera (PV) is associated with high morbidity and mortality for thrombosis. We hypothesized that in PV altered sensitivity to aspirin might be related to dysfunction of the endothelial repair and/or of the nitric oxide (NO) system. Urinary thromboxane (TX) A 2 metabolite (TXM). endothelial colony-forming cells (ECFCs), plasma asymmetric dimethyl- arginine (ADMA) and von Willebrand factor (VWF) were measured in 37 PV patients on low-dose aspirin and 12 healthy controls. Patients showed an approximately 2-fold increase in median TXM and plasma ADMA levels (P2 = 0.39). Serum TXB 2, measured in 22 patients, was approximatly 10-fold higher than aspirin-treated controls. PV patients appear to have an unbalanced ECFC/NO axis, and an apparent altered sensitivity of platelet TXA 2 production, all potentially contributing to aspirin- insensitive TXM formation. Thus, additional antithrombotic strategies may be beneficial in PV.

UR - http://www.scopus.com/inward/record.url?scp=51649130509&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=51649130509&partnerID=8YFLogxK

U2 - 10.1182/blood-2007-11-123091

DO - 10.1182/blood-2007-11-123091

M3 - Article

VL - 112

SP - 1085

EP - 1090

JO - Blood

JF - Blood

SN - 0006-4971

IS - 4

ER -